Mirae Asset Global Investments’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Buy |
3,079
+415
| +16% | +$22.1K | ﹤0.01% | 1071 |
|
|
2025
Q1 | $114K | Buy |
2,664
+338
| +15% | +$14.4K | ﹤0.01% | 1110 |
|
|
2024
Q4 | $65.7K | Sell |
2,326
-185
| -7% | -$5.23K | ﹤0.01% | 1223 |
|
|
2024
Q3 | $70.9K | Buy |
2,511
+446
| +22% | +$12.6K | ﹤0.01% | 1241 |
|
|
2024
Q2 | $48.3K | Sell |
2,065
-23,593
| -92% | -$552K | ﹤0.01% | 1257 |
|
|
2024
Q1 | $845K | Sell |
25,658
-14,227
| -36% | -$469K | ﹤0.01% | 1627 |
|
|
2023
Q4 | $931K | Buy |
39,885
+9,567
| +32% | +$223K | ﹤0.01% | 1659 |
|
|
2023
Q3 | $1.53M | Buy |
30,318
+3,499
| +13% | +$177K | ﹤0.01% | 1301 |
|
|
2023
Q2 | $1.24M | Buy |
26,819
+4,332
| +19% | +$200K | ﹤0.01% | 1444 |
|
|
2023
Q1 | $860K | Buy |
22,487
+6,203
| +38% | +$237K | ﹤0.01% | 1621 |
|
|
2022
Q4 | $892K | Buy |
16,284
+3,307
| +25% | +$181K | ﹤0.01% | 1560 |
|
|
2022
Q3 | $442K | Buy |
+12,977
| New | +$442K | ﹤0.01% | 1946 |
|